Study of sex difference in pathogenesis of heart failure and development of preventive strategy

Study of sex difference in pathogenesis of heart failure and development of preventive strategy - Study of sex difference in heart failure

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052673

Enrollment

300

Registered

2023-11-01

Start date

2023-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with heart failure. Patients who have no medical history of heart failure and have one more cardiovascular risks(Hypertension, Diabetes Mellitus, Obesity, Atrial Fibrillation).

Exclusion criteria

Exclusion criteria: Patients who have received hormone replacement therapy within one year.

Design outcomes

Primary

Measure	Time frame
Sex hormones and circulating micro-RNAs of heart failure patients	—

Countries

Japan

Contacts

Public ContactMasayuki Toyoda

The University of Tokyo Hospital Department of Cardiovascular Medicine

mtoyoda-tky@g.ecc.u-tokyo.ac.jp03-3815-5411

Outcome results